The Berlin-based start-up Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and the Institute of Medical Genetics and Human Genetics at the Charité – Universitätsmedizin Berlin, has raised €1.3 million in pre-seed funding in a funding round led by Caesar Ventures, with support from BIF Partners, another.vc and the MPF Accelerator. The funds will be used to further expand their AI-Digital HealthTech Platform, which extracts all genomic information to improve diagnostics and drug discovery.